The AngioSculpt Scoring Balloon Catheter provides an innovative clinical solution for a peak performance in Peripheral Angioplasty. It significantly alters the landscape for treating peripheral artery disease or PAD. It is designed to address a wide range of peripheral lesions that includes the most challenging and complex types. About 98.8% of lesions are successfully deployed. 84.9% of these lesions have procedural success without adjunctive stenting. It is also proven effective in complex calcified lesion (67.4%), bifurcation (25.6%) and ostial (15.1%) lesion. The Catheter is also has a significant low dissection rate of 1.8% vs 30% for POBA2 in a recent clinical study. It is efficient in treating CLI with 82.5% of patients Rutherford Class >_ 41. The AngioSculpt Scoring Balloon Catheter provides the versatility and effectiveness that is required by a new technology combined with simplicity, deliverability and reduced procedure time of a high-performance balloon catheter.